Vitamin D3 (vitD3) and its active metabolite, calcitriol (1,25-(OH)2D3), affect multiple tissue types by interacting with the vitamin D receptor (VDR). Although vitD3 deficiency has been correlated with increased incidence of breast cancer and less favorable outcomes, randomized clinical trials have yet to provide conclusive evidence on the efficacy of vitD3 in preventing or treating breast cancer. Additionally, experimental studies are needed to assess the biological plausibility of these outcomes. The mammary gland of VDR KO mice shows a florid phenotype revealing alterations of developmental processes that are largely regulated by mammotropic hormones. However, most research conducted on vitD3’s effects used 2D cell cultures and supra-physiological doses of vitD3, conditions that spare the microenvironment in which morphogenesis takes place. We investigated the role of vitD3 in mammary epithelial morphogenesis using two 3D culture models. VitD3 interfered with estrogen’s actions on T47D human breast cancer cells in 3D differently at different doses, and recapitulated what is observed in vivo. Also, vitD3 can act autonomously and affected the organization of estrogen-insensitive MCF10A cells in 3D collagen matrix by influencing collagen fiber organization. Thus, vitD3 modulates mammary tissue organization independent of its effects on cell proliferation.
Breast cancer remains a major cause of mortality among women worldwide. Epidemiological studies have shown that key stages during breast development are particularly susceptible to the effects of carcinogens. For instance, women aged 10–19 years who were exposed to atomic bomb radiation in Hiroshima during World War II showed an increased incidence of breast cancer at the age of prevalence compared to similarly exposed women aged 35 years and older1. Likewise, women exposed to diethylstilbestrol during fetal life have a higher risk of breast cancer compared to unexposed women2, and women exposed to DDT in the womb showed a four-fold higher risk of breast cancer in adulthood3. Windows of susceptibility have also been observed in rodents; namely, rats exposed to the carcinogen nitrosomethylurea around puberty have a 100% incidence of tumors, but the incidence rate falls to just 10% when exposed to the carcinogen after 90 days of age4. Rodents exposed in utero to low doses of BPA have also shown a higher incidence of mammary gland tumors in adult life5,6. These windows of susceptibility coincide with key milestones of organogenesis and/or tissue remodeling, buttressing the notion that carcinogenesis should be considered as “development gone awry7.”
Vitamin D3 (VitD3), and its active metabolite calcitriol (1,25-(OH)2D3), has been primarily studied in the context of normal and diseased bone development8. However, research over the past few decades have shown that vitD3 can affect multiple tissue types, including the mammary gland8. For instance, epidemiological data from human populations across different ethnicities and latitudes showed a correlation between vitD3 deficiency and risk of breast cancer incidence, and also between vitD3 deficiency and worse outcomes for breast cancer patients8,9,10. Animal models showed that calcitriol deficiency promotes mammary tumor growth in mice11 and vitamin D receptor (VDR) KO animals have a higher mortality rate when they were crossed into a genetically induced breast cancer model background12. Moreover, dietary supplementation of vitD3 inhibited tumor growth in xenograft models of mammary and prostate cancers in mice13. Although vitD3 supplementation may help with patient outcomes, and post-menopausal women may benefit from a lower breast cancer risk14, there is yet no conclusive evidence from randomized clinical trials that validates the efficiency of vitD3 as a therapeutic or preventive option for breast cancer.
Mammary glands of VDR KO mice exhibited a florid developmental phenotype, as exemplified by increased number of terminal end buds, increased ductal extension and lateral branching at puberty15, precocious alveologenesis during pregnancy, and delayed post-lactational involution16. These developmental processes are largely influenced by the so-called mammotropic hormones, i.e., Estrogen (E), Progesterone (Prg) and Prolactin (Prl). More specifically, E induces ductal elongation, Prg increases lateral branching and Prl stimulates alveologenesis17. The VDR KO phenotype in the mammary gland of rodents indicates that vitD3 interacts with these hormones during mammary epithelial morphogenesis. However, the interactions between these mammotropic hormones and vitD3 and the role of vitD3 in mammary epithelial morphogenesis at these developmental stages have yet to be examined.
Studies on vitD3’s action in the mammary gland have largely focused on vitD3’s effects on cell proliferation and apoptosis8. Because these studies have mostly utilized 2D cell culture models, they do not represent the 3D environment required for morphogenesis. Additionally, most studies have used a calcitriol dose of 100 nM, a dose chosen based on the deficiency cut-off level for vitD3 in human populations that is determined by measuring the serum levels of calcidiol, the precursor to calcitriol18. Therefore, utilizing such a dose assumes a hundred percent conversion rate of calcidiol to calcitriol locally at specific tissues, while not taking into account that calcitriol may elicit a non-monotonic dose response comparable to that observed with other steroid hormones.
In this current study, we have utilized two different 3D cell culture models to investigate vitD3’s role in mammary gland morphogenesis. We observed that calcitriol constrains estradiol’s actions on the organization of mammary epithelial cells, and that this effect is independent of its already well-characterized role in cell proliferation. We also noticed that calcitriol has autonomous effects on mammary ductal organization and describe a novel effect of calcitriol on the organization of collagen fibers. Finally, calcitriol elicited a non-monotonic dose response in mammary epithelial cells, as can be expected from a steroid hormone.
Effects of calcitriol on estrogen-induced cell proliferation
The human breast epithelial T47D cell line is hormone responsive and proliferates in response to estradiol (E2) in both 2D and 3D cultures19. Both in 2D and 3D cultures T47D cells exposed to different doses of calcitriol showed a decrease in cell numbers at the end of a 6-day period only when in the presence of estradiol (E2) (Fig. 1). However, the reduced cell yield was observed at the 50 nM and 100 nM doses of calcitriol alone in 2D (Fig. 1A), whereas a reduced cell yield was observed only at the 100 nM dose in 3D (Fig. 1B). Based on our inverted microscope visualization of dead “floaters” in these cultures, the decrease in cell yield, especially in 2D culture, could be attributed to cell death. It has been previously described that MCF7 cells treated with 100 nM calcitriol, considered supra-physiological20, for 48 hours resulted in a decreased percentage of cells in S-phase21. To test whether cell cycle arrest contributed to the reduction in cell yield, we utilized a concentration that did not result in cell death (25 nM). Using propidium iodide and flow cytometry, we observed that the percentage of cells in S-phase did not deviate significantly between the 0. 1 nM E2 and 25 nM (+E2) treatments over 4 days. In contrast, there was a marked reduction of cells entering S-phase in the control (CD) group starting at day 2 (Supplementary Fig. 1); this reduction was statistically significant at days 3 and 4. We also observed that the percentage of cells in S-phase in the E2+ 25 nM calcitriol treated group was significantly reduced on day 4 (Supplementary Fig. 1).
In our 3D cultures, we also observed an increase in cell numbers at lower calcitriol doses, such as 10 and 25 nM in 3D culture, an outcome that has not been previously reported (Fig. 1B). Separately, calcitriol activity in these cells was confirmed by performing RT-PCR for CYP24A1 gene transcripts that showed a dose-dependent increase following calcitriol treatment (Supplementary Fig. 2).
Effects of calcitriol on estrogen-induced epithelial organization
Previous work from our lab had shown that E2 induces T47D cells to form mostly elongated shaped structures when embedded in a 3D rat tail collagen type I matrix19. Using this same model, we investigated how vitD3 affects the organization of T47D cells in the presence of 0.1 nM E2; epithelial structures in whole-mounted 3D gels, stained with carmine alum, were imaged using confocal microscopy. As shown in Fig. 2A, calcitriol affected the organization of these cells, mainly by modifying the volume of the epithelial structures in a dose-dependent manner (Supplementary Fig. 3). More specifically, the change in the organization is seen through a re-distribution of different sized structures in the population – the 50 nM calcitriol dose resulted in a higher number of smaller structures whereas the 10 nM dose resulted in a slight, non-statistically significant increased number of larger structures (Fig. 2B). We also observed that there was a concomitant decrease in the number of larger structures in the 50 nM calcitriol (+E2) dose. In contrast, calcitriol alone did not seem to affect these cells when added to medium supplemented with fetal bovine serum (FBS) which was charcoal-dextran (CD) treated to remove estrogens. This outcome suggests that either the interactions with E2 were responsible for the effects observed, or the effect of calcitriol is independent of E2 but was unobservable as the cells do not proliferate in the absence of E2.
Further investigation into vitD3’s effects on epithelial organization in 3D cultures using our unsupervised and unbiased analysis software, Software for Automated Morphometric Analysis (SAMA)22, revealed that calcitriol affects morphological parameters of the T47D epithelial structures, also in a dose-dependent manner. The 50 nM calcitriol dose resulted in a reduction in the major radius of the ellipsoid (ell_majrad; Fig. 3A) and an increase in the elongation ratio (elon1; Fig. 3B); this observation suggests that this dose results in smaller and thinner structures compared to those induced by 0.1 nM E2. In contrast, the 10 nM calcitriol dose resulted in a decrease in sphericity (Fig. 3C) and an increase in the flatness ratio (elon2; Fig. 3D); in this condition, the T47D structures were more elongated and wider compared to those in the E2 control.
Calcitriol interferes with estrogen’s transcriptional effects
Previous studies have indicated that vitD3 interferes with E2-induced gene expression in cells in culture and human breast tissue23. To delineate whether vitD3 was interacting with E2’s activity at the transcriptional level, we extracted RNA from T47D cells in 3D gels and performed RT-PCR to examine the levels of progesterone receptor gene (PGRAB) transcripts, which are a reliable indicator of E2’s activity both in vitro and in vivo. We observed that both 50 and 100 nM calcitriol diminished PGRAB induction by E2 by ~60% in T47D cells in 3D culture, as shown in Fig. 4A. This indicates that in our model calcitriol interferes with E2’s activity at the transcriptional level. Published work by others24,25 have indicated that calcitriol treatment decreases estrogen receptor α (ERα) expression both at the protein and mRNA levels in MCF7 cells grown in 2D culture. We found that calcitriol treatment (50 or 100 nM, +E2) did not alter ERα mRNA levels in T47D cells in 3D culture (Fig. 4B).
Estrogen-independent effects of vitD3
MCF10A cells are considered normal breast epithelial cells because they do not form tumors when inoculated into nude/SCID mice26 and form normal acinar and ductal structures in 3D cultures27. To investigate whether vitD3 has autonomous effects on mammary epithelial cell proliferation and organization, we chose to investigate calcitriol’s effects on MCF10A cells under those conditions. MCF10A cells are ER negative; they respond to calcitriol in a dose-dependent manner as shown by the induction of CYP24A1 gene transcripts (Supplementary Fig. 4). Because calcitriol exposure resulted in lower cell numbers starting at 10 nM in 3D compared to 50 nM in 2D culture, these cells appear to be more sensitive to calcitriol in 3D culture conditions (Fig. 5). MCF10A cells exhibited a monotonic dose-response relationship in both cases.
Autonomous effects of calcitriol on epithelial organization
Consistent with previous findings28,29, MCF10A cells formed mostly acinar structures with few ductal structures when embedded in a rat tail type I collagen matrix and cultured for 2 weeks (Fig. 6A). Interestingly, calcitriol increased the number of elongated structures in 3D culture with the highest number observed at the 10 nM dose, followed by a reduction at higher doses (25 and 50 nM, Fig. 6B).
Effects of calcitriol on MCF10A epithelial organization
Confocal images of MCF10A 3D gels were analyzed for changes in the morphological parameters of the epithelial structures upon calcitriol treatment; representative optical sections (1 µm thick) of MCF10A structures from different treatment groups are shown in Fig. 7A. Exposure to calcitriol resulted in flatter (elon2, Fig. 7B) and less spherical (sphericity, Fig. 7B) structures; these effects were significant at 25 and 50 nM doses for the former and all calcitriol doses for the latter. Calcitriol also resulted in a significant decrease in the volume of these epithelial structures at 25 and 50 nM doses (volume, Fig. 7B), which can be attributed to the increase in flatness with increasing calcitriol doses. The increase in flatness, and the decrease in sphericity and volume of these structures change their shape from a sphere towards an oblate (flattened spheroid). This is reflected in a dose-dependent significant decrease in the ratiovolellipsoid measure (Fig. 7B) - ratiovolellipsoid measures how close to a sphere a structure is and a value of “1” represents a perfect sphere22.
Effects of calcitriol on collagen organization
MCF10A cells organize collagen fibers in the 3D gels as a prerequisite for organizing into ducts or acini30. We investigated collagen fiber organization in 3D gels using picrosirius red staining. Polarized light microscopy of formalin-fixed, paraffin-embedded (FFPE) sections stained with picrosirius red revealed that calcitriol has a non-monotonic effect on collagen fiber organization in this 3D model (Supplementary Fig. 5). Calcitriol at a 10 nM dose reduced the number of organized collagen fibers. In contrast, 25 and especially 50 nM doses showed an increase in the amount of organized collagen fibers. Additionally, at these doses, organized fibers were more uniformly distributed throughout the 3D gels, especially in areas distal from epithelial structures (data not shown). On closer inspection using second harmonic generation (SHG) imaging technique, we observed a higher intensity of SHG signals, which correspond to thicker fiber bundles31 around epithelial structures in gels treated with higher (25 and 50 nM) calcitriol doses compared to those in untreated and 10 nM treated gels (Fig. 8A). In gels treated with 10 nM calcitriol, we observed longer, organized collagen fibers around the epithelial structures; the SHG signal intensity was similar to that in untreated gels. Given the flattening phenotype observed in MCF10A structures when treated with calcitriol, and based on the evidence from collagen fiber visualization, we hypothesized that cells must be experiencing greater physical forces at higher calcitriol doses. Cells respond to external mechanical forces by generating endogenous stress through myosin and actin network32; we therefore visualized actin filaments using rhodamine-labeled phalloidin. Thicker actin bundles were present in the periphery of the epithelial structures in gels treated with calcitriol (Fig. 8B). These observations may explain why calcitriol treatment results in increased contraction of the 3D gels in a dose-dependent manner after 2 weeks in culture (Fig. 8C).
Despite evidence linking vitD3 deficiency to increased risk of breast cancer and worse clinical outcomes in patients, randomized clinical trials have yet to confirm the efficacy of vitD3 as a preventive or therapeutic option in this disease8. Experimentally, while VDR KO mice do not develop tumors spontaneously, mammary glands from these mice exhibit a striking phenotype of excessive and precocious development at key stages15,16. This suggests that vitD3 plays an important role in the development of the normal mammary gland. When considering that carcinogenesis results from altered tissue architecture during development (development gone awry) and tissue remodeling7, an understanding of the role of vitD3 in this process may provide worthy therapeutic options for breast cancer patients.
The VDR is expressed in the mammary gland at the different stages of postnatal development that are largely influenced by the mammotropic hormones E2, Prg and Prl. These hormones have well-characterized effects on the morphogenesis of the gland; for example, E2 promotes ductal elongation, Prg increases lateral branching and Prl induces alveologenesis17. Although the VDR KO phenotype of the gland has been described15,16, no reference has been made so far to the interactions between E2, Prg and Prl, and vitD3 in a 3D environment in which morphogenesis takes place. To fulfill this need, we have utilized two different 3D culture models to tease out vitD3’s effects that are either dependent or independent of its interactions with E2. We noticed that calcitriol exhibits a non-monotonic dose response only in 3D cultures, an outcome not previously described. This is in line with current knowledge regarding steroid hormone activity33 and also favors the notion that vitD3 functions as a steroid hormone.
In the presence of estrogen in 3D culture, calcitriol increased total cell yield at the 10 nM dose whereas it decreased total cell yield at the 100 nM dose (Fig. 1B). This reduced cell yield can be attributed to cell death given our observation of floater cells in both 2D and 3D cultures. Comparable evidence was found when the role of vitD3 was explored in apoptosis8,23; the notion that cell cycle arrest could have been responsible for the reduced cell yield was disproven by our T47D cell cycle analysis experiment (Supplemental Fig. 1). We also observed that calcitriol constrained the effects of E2 on mammary epithelial morphogenesis without affecting total cell yield, more specifically on the organization of epithelial ductal structures in 3D conditions. Consistent with our finding, the mammary glands of CYP24A1 KO mice, which cannot metabolize calcitriol, exhibit stunted development34; Zinser et al.16 report that VDR KO mammary glands exhibit increased ductal elongation at puberty. Of note, in both of these models, the proliferative capacity of the epithelial cells was not affected. Given that E2 is responsible for ductal elongation during puberty, our results recapitulate vitD3’s activity in vivo and confirm that calcitriol at high doses constrains the effects of estrogen on ductal elongation without affecting cell death or proliferation.
The observation that 10 nM calcitriol increased total cell yield in the presence of E2 in 3D culture challenges the commonly reported apoptotic effects of calcitriol8,23. To the best of our knowledge, this is the first report of calcitriol increasing breast epithelial cell yield in 3D culture. Previously, only two papers35,36 had reported increased cell numbers at calcitriol doses between 0.05 and 0.8 nM in 2D culture. However, we were unable to reproduce these outcomes using cell culture materials from both the same and a different brand, and using two different methodologies – measuring doubling time (data not shown) and total cell yield. We observed a non-significant increase in total cell number in the 0.1 nM calcitriol dose in the presence of estradiol (Fig. 1A).
During puberty, the mouse mammary gland epithelial ducts elongate under the influence of E2. However, only 15–20% of epithelial cells in the gland are ER-positive at that time37, with this protein being expressed in the interior luminal layer of epithelial cells and not in the outermost cap layer. A similar pattern of VDR expression in the mammary gland epithelium at puberty has been reported with most expression observed in the trailing edge of the terminal end buds and lesser expression in the cap cells15. Therefore, while E2 appears to bind to ER present in 15–20% of epithelial cells during puberty, its effects are observed at the tissue level.
In order to investigate whether vitD3 autonomously affects epithelial cells beyond its interactions with E2, we utilized an estrogen-insensitive 3D culture model. MCF10A cells, considered to portray a “normal-like” behavior in vitro, organize into mostly acini and form some ductal structures in the 3D collagen matrix27. We observed that vitD3 retains its non-monotonic effects on morphogenesis even in an estrogen-insensitive 3D culture model. We showed that this organization of MCF10A cells is affected in a dose-dependent manner when treated with calcitriol in 3D cultures. These cells showed a greater sensitivity to calcitriol in 3D when compared to 2D cultures, with cell death increasing in a dose-dependent manner upward from a 10 nM dose (Fig. 5).
Mechanical forces are the main mediators of shape during morphogenesis. Previously, we have shown that mammary epithelial cells embedded in a type I collagen matrix manipulate the collagen fibers around them in the process of organizing into complex shapes such as ducts and acini19,30; these epithelial cells exert mechanical forces that act on collagen fibers and on neighboring cells. As fibers organize, they constrain the cells on their ability to move and to proliferate38. We have also shown that hormones distinctively influence the way epithelial cells organize collagen fibers, and consequently determine the shape of the structures formed19,31. Based on these results, we hypothesized that vitD3 would also affect fiber organization, which in turn would affect the mechanical environment of the cells. MCF10A cells treated with increasing concentrations of calcitriol in 3D cultures increased the contraction of gels. Treatment with calcitriol also decreased the number of cells in the gels in a dose-dependent manner. Gel contraction is dependent on the number of cells present in the gel and on the manipulation of collagen fibers by the cells. While the lower number of cells can account for the smaller sizes of structures observed in the 3D gels treated with calcitriol, this association does not explain the increased contraction of these gels. Picrosirius red staining revealed that even though there are fewer cells in the gels at all calcitriol doses compared to untreated gels, there is a more uniform distribution of organized fibers throughout the gel (Supplementary Fig. 5). High resolution imaging using SHG microscopy revealed longer bundles of fibers at all calcitriol doses, and thicker bundles of fibers at 25 and 50 nM doses (Fig. 8A). Organized fibers are responsible for transmission of forces39. Cells respond to external mechanical force by generating endogenous stress using myosin and actin networks32. Using rhodamine-labeled phalloidin to visualize actin filaments, we observed thicker and pronounced actin networks in the boundaries of the epithelial structures in gels treated with calcitriol (Fig. 8B). This suggests that MCF10A cells experience greater mechanical forces with increasing calcitriol concentration. The increased contraction of the gels (Fig. 8C) can therefore be explained by the transmission of forces generated by the cells on collagen fibers over long distances40.
We observed that at the 10 nM dose of calcitriol there was the least amount of fiber bundles, as visualized when using picrosirius red dye and polarized light microscopy (Supplementary Fig. 5) and the highest number of elongated structures (Fig. 6B). On closer observation, the calcitriol treated gels contained a lower number of branched, elongated structures (ductal, tubular) and a higher number of unbranched, elongated structures (cord-like). Additionally, when compared to untreated gels, increase in calcitriol dose resulted in shorter and thinner elongated structures. We have previously reported that MCF10A cells embedded in a collagen type I matrix form ductal/tubular structures in the periphery of the gel41. In the 25 and 50 nM calcitriol- treated gels, cord-like structures were observed in the periphery and in the inner areas. In higher resolution images obtained using SHG microscopy, we observed that at the 10 nM dose, while the signal intensity is similar to untreated, the fiber bundles around epithelial structures were longer (Fig. 8A). This may explain the phenotype of epithelial structures observed at the 10 nM dose. We hypothesize that the longer organized bundles facilitate the formation of tubular structures, while at the higher doses of calcitriol, the thicker fibers force the cells to organize in cord-like structures. Additional measurements of local biomechanical parameters in the calcitriol-treated 3D gels are required to test this hypothesis and to elucidate the differential organization of structures depending on the calcitriol dose used.
By definition, all models are simplified versions of the object being modeled. They are used precisely because they reduce the number of variables considered relevant to explain a phenotype. Thus, like all experimental models, 3D culture models have their limitations. For example, the use of established cell lines, which are considered rather stable is dictated by the limitations of using freshly isolated primary cells. Isolated human primary cells are not efficient in forming biologically relevant structures in collagen or ECM matrices in vitro; only a small percentage of them express mammotropic hormone receptors and they lose their potential to form structures shortly after being placed in culture42,43,44. Considering these inherent limitations, we have utilized human breast epithelial cell lines such as T47D and MCF10A to create more robust, consistent and complementary models that would still mimic the mammary gland morphogenesis observed in vivo.
Future work should incorporate findings from in vitro 3D models and test them in an in vivo model. To that end, findings that calcitriol constrains the action of estrogen can be incorporated into a mammary gland tissue recombination model between VDR KO and wild type animals to investigate the role of the stromal and epithelial compartments in mediating vitD3’s effects during pubertal development. Similarly, a fetal mammary gland ex vivo culture model45 can also be utilized to more comprehensively understand the role of vitD3 in early development.
Finally, we have shown that calcitriol, at physiologically relevant doses, have effects beyond cell death and proliferation described in the current literature. This study highlights the role of vitD3 as a morphogen to the extent that calcitriol contributes to the proper shaping of the mammary gland epithelium during development. Disorganization of the tissue architecture during early developmental phases has been shown to contribute to tumor formation in the mammary gland6,46. This study provides a more detailed understanding of vitD3’s role in normal mouse mammary gland development and a lead on how vitD3 deficiency might contribute to increased breast cancer risk.
Materials and Methods
Hydrocortisone, cholera toxin, insulin, Dulbecco’s modified Eagle’s medium (DMEM), Phosphate Buffered Saline (PBS, 10×), propidium iodide, RNase A, and calcitriol were purchased from Sigma-Aldrich (St. Louis, MO). DMEM/F12, L-Glutamine and Trypsin were from Life Technologies (Carlsbad, CA). 17β-estradiol (E2) was purchased from Calbiochem. Fetal bovine and equine sera were supplied by Thermo Fisher (Waltham, MA). Epidermal Growth Factor (EGF) and rat tail type I collagen were from Corning (Tewksbury, MA). E2 and calcitriol were resuspended in ethanol to make 10−3 and 10−4 M stocks, respectively; calcitriol stocks were stored under nitrogen at −20 °C. RNase A was diluted at 2 mg/mL in distilled, de-ionized water and stored according to manufacturer’s instructions.
Human breast epithelial T47D cells used in this study were cloned from a population originally obtained from Dr. G. Green (U. Chicago). T47D cells were routinely tested to ascertain their estrogen-sensitivity before performing experiments with them47. These cells were grown in DMEM containing 5% FBS (propagation medium). When looking at effects of hormones on these cells using 2D culture experiments, we used DMEM/F12 without phenol red with 5% charcoal-dextran stripped FBS (CD-FBS) and 106 U/ml penicillin. When performing 3D culture experiments with the same purpose, we used a mixture of 75% DMEM, 25% Ham’s F12 without phenol red, 7.5% CD-FBS and 2 mM L-glutamine. Human breast epithelial MCF10A cells were purchased from American Type Culture Collection (Manassas, VA) and maintained in DMEM/F12 with phenol red, 5% equine serum, 20 ng/ml EGF, 0.5 µg/ml hydrocortisone, 0.1 µg/ml cholera toxin, and 10 µg/ml insulin. Experiments performed using MCF10A cells used the same medium. In all cases, cells were incubated at 37 °C in 6% CO2 and 100% humidity.
Dose response curves to calcitriol
Dose-response curves to calcitriol in 2D culture were performed in 24-well plates. Cells were seeded at a density of 35,000/well in media and allowed to attach. For MCF10A cells, seeding media was changed to media containing different doses of calcitriol after 24 hours of seeding. For T47D cells, propagation media was removed 48 hours after seeding, and substituted with CD-FBS medium containing different doses of calcitriol with or without E2. After 6 days, cell numbers were determined using the SRB assay48.
Cell Cycle Analysis
T47D cells were seeded in T25 flasks at a concentration of 1 × 106 cells per flask and allowed to attach. After 48 hours, media was replaced with proper treatment media (CD-FBS alone, plus 0.1 nM E2, plus 25 nM calcitriol and 0.1 nM E2) and cells were incubated up to 4 days. Cells were harvested every day through trypsinization and pelleted by centrifuging at 1200 rpm for 3 mins. Cell pellets were washed with 5 mL ice-cold PBS, fixed in 5 mL 70% ethanol with 0.5 mL cold PBS, followed by another PBS wash. Cells were then incubated in the dark for 45 mins with 500 uL RNase A and 500 uL propidium iodide solution (0.1 mg/mL in 0.6% triton-x diluted in PBS). Stained cells were filtered using a 40 µm cell strainer to ensure single cell suspension before analysis on FACSCalibur flow cytometer (BD Biosciences, CA).
Collagen type I gels were formulated at a final concentration of 1 mg/mL as described previously19. Cells were suspended in the gel solution at a density of 75,000 cells per gel and 1.5 mL of mixture (per well) was poured into 12-well plates. The mixture was allowed to congeal for 30 min at 37 °C, and 1.5 mL of appropriate media was added to each well (CD-FBS media containing E2 +/− calcitriol for T47D, MCF10A media +/− calcitriol). Gels were detached as previously described41. Cultures were maintained either for 1 week to measure total cell yield or 2 weeks for morphological assessments. At each endpoint, gels were harvested and processed as described by Speroni et al.19. Briefly, to estimate cell numbers, cells were extracted by digesting 3D gels with collagenase and then lysed to obtain nuclei that were then counted using a Coulter Z1 particle counter (Beckman Coulter, CA). For morphological assessments, gels were harvested at 2 weeks, fixed with 10% phosphate-buffered formalin, and cut in half. One half was embedded in paraffin, sectioned at 5 um thickness, and stained with Harris’ Hematoxylin and eosin (H&E) for histological analyses. The other was whole mounted and stained with carmine alum to visualize epithelial structures. The diameter of MCF10A gels was measured at the longest axis with a ruler post-fixation and prior to further processing.
Whole mount analysis
Whole-mounted gels stained with carmine alum were imaged using a Zeiss LSM 800 confocal microscope for automated morphometric analysis as described by Paulose et al.22. Briefly, ~1 mm2 area of the gel periphery was imaged to a depth of ~100 µm. Resulting images were stitched together and analyzed using SAMA22 and statistical analyses of morphometric parameters was performed using GraphPad Prism software.
Picrosirius red staining
FFPE gels were sectioned using a microtome at 5 µm thickness. Gel sections were then rehydrated and stained with picrosirius red solution to visualize collagen fibers and counter-stained with Weigert’s hematoxylin as described by Junqueira et al.49. Stained sections were observed under polarized light using a Zeiss Axioskop 2 Plus microscope.
Collagen gels were harvested and fixed with freshly prepared 2% paraformaldehyde in PBS. The gels were then permeabilized with 0.2% Triton X-100 in PBS followed by washes in PBS and a 1-hour incubation at room temperature with rhodamine-labeled phalloidin (Cytoskeleton Inc., CO) at 1:100 dilution in PBS. The gels were then washed with PBS and counterstained with DAPI (2.5 ug/mL, Sigma-Aldrich), mounted with anti-fade mounting medium (0.02% n-propyl gallate in 80% glycerol) and visualized with Zeiss LSM 800 confocal microscope.
Second harmonic generation microscopy
SHG images of collagen fibers and two photon excitation fluorescence (TPEF) images of epithelial structures were obtained using a Leica TCS SP8 confocal microscope equipped with a tunable (680–1,300 nm) titanium-sapphire laser (Insight DS+, Spectra Physics, CA). Non-descanned low-noise Leica hybrid (HyD) detectors collected light in the 460 +/− 25 nm (SHG) and 525 +/− 25 nm (TPEF) ranges at an excitation wavelength of 920 nm. In this study, we used a water-immersion 40x objective (NA 1.10, 650 um working distance). Images with a size of 512 × 512 (pixel size 284 × 284 nm) were acquired at an interval of 1 um along the z-axis. While efforts were made to only include one epithelial structure in a 3D stack, it was not always possible especially at the higher calcitriol doses given the contraction of the gels and the consequent crowding of the structures. Reconstruction of 3D images was performed using FIJI (National Institutes of Health, USA).
Gels were digested using collagenase as described above, and RNA from cells was harvested using Qiagen RNeasy mini kit according to manufacturer’s instructions. Gene transcripts were quantified via RT-PCR using the Luna Universal One-Step RT-qPCR kit (New England Biolabs, MA) in an iQ5 thermocycler (Bio-rad, CA). Transcript levels were normalized to RPL19 transcripts levels. Primer sequences for genes analyzed are as follows - PGRAB 5′-GAGGATAGCTCTGAGTCCGAGGA-3′ (forward), 5′-TTTGCCCTTCAGAAGCGG-3′ (reverse); RPL19 5′-TAGTCTGGCTTCAGCTTCCTC-3′ (forward), 5′-TCTGCAACATCCAGCTACCC-3′ (reverse); CYP24A1 5′-GAAAGAATTGTATGCTGCTGTCACA-3′ (forward), 5′- GGGATTACGGGATAAATTGTAGAGAA-3′ (reverse); ESR1 5′-TAAATGCTGCCATGTTCCAA-3′ (forward), 5′-CCTGTGAGAGAACAGAAACTGG-3′ (reverse).
GraphPad Prism and SPSS software were used for all statistical analyses. One-way ANOVA followed by Tukey’s post hoc test were performed to determine differences in the dose-response curves, number of elongated structures in MCF10A gels, MCF10A gel diameters, and percentage of cells in S-phase; one-way ANOVA with post hoc Dunnett’s 2-sided t-test was performed for cell yields in T47D 3D gels. Kruskal-Wallis test was performed to determine differences in the morphometric parameters of structures. Chi-square analysis was performed to compare distributions of T47D epithelial structures in different volume categories. Unpaired t-test with Welch’s correction was used to analyze RT-PCR data. For all statistical tests, results were considered significant at p < 0.05.
All data generated or analyzed during the current study are available from the corresponding author on reasonable request.
McGregor, H. et al. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950–69. J. Natl. Cancer Inst. 59, 799–811 (1977).
Palmer, J. R. et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiology, Biomarkers &. Prevention 15, 1509–1514 (2006).
Cohn, B. A. et al. DDT exposure in utero and breast cancer. Journal of Clinical Endocrinology and Metabolism 100, 2865–2872 (2015).
Thompson, T. A., Haag, J. D. & Gould, M. N. ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats. Carcinogenesis 21, 1917–1922 (2000).
Acevedo, N., Davis, B., Schaeberle, C. M., Sonnenschein, C. & Soto, A. M. Perinatally administered Bisphenol A as a potential mammary gland carcinogen in rats. Environ Health Perspect 121, 1040–1046 (2013).
Vandenberg, L. N. et al. Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice. Reproductive Toxicology 26, 210–219 (2008).
Soto, A. M., Brisken, C., Schaeberle, C. M. & Sonnenschein, C. Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors. Journal of Mammary Gland Biology and Neoplasia 18, 199–208 (2013).
Feldman, D., Krishnan, A. V., Swami, S., Giovannucci, E. & Feldman, B. J. The role of vitamin D in reducing cancer risk and progression. Nature Reviews: Cancer 14, 342–357 (2014).
Estébanez, N., Gómez-Acebo, I., Palazuelos, C., Llorca, J. & Dierssen-Sotos, T. Vitamin D exposure and risk of breast cancer: a meta-analysis. Sci.Reports 8, 9039 (2018).
O’Brien, K. M., Sandler, D. P., Taylor, J. A. & Weinberg, C. R. Serum vitamin D and risk of breast cancer within five years. Environmental Health Perspectives 125, 077004 (2017).
Jeong, Y. et al. Inhibition of mouse breast tumor-initiating cells by calcitriol and dietary vitamin D. Mol.Cancer Ther. 14, 1951–1961 (2015).
Zinser, G. M. & Welch, J. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis 25, 2361–2372 (2004).
Swami, S. et al. Dietary vitamin D3 and 1,25-dihydroxyvitamin D3 (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Endocrinology 153, 2576–2587 (2012).
de Sousa Almeida-Filho, B. et al. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women. J. Steroid Biochem. Mol. Biol. 174, 284–289 (2017).
Zinser, G. M., Packman, K. & Welch, J. Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development 129, 3067–3076 (2002).
Zinser, G. M. & Welsh, J. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Molecular Endocrinology 18, 2208–2223 (2004).
Brisken, C. & O’Malley, B. Hormone action in the mammary gland. Cold Spring Harb. Perspect. Biol. 2, a003178 (2010).
Hollis, B. W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135, 317–322 (2005).
Speroni, L. et al. Hormonal regulation of epithelial organization in a 3D breast tissue culture model. Tissue Eng. Part C Methods 20, 42–51 (2014).
Milani, C. et al. Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture. BMC Cancer 13, 119, https://doi.org/10.1186/1471-2407-13-119 (2013).
Simboli-Campbell, M., Narvaez, C. J., van Weelden, K., Tenniswood, M. & Welsh, J. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Research and Treatment 42, 31–41 (1997).
Paulose, T. et al. SAMA: A method for 3D morphological analysis. PLoS ONE 11, e0153022 (2016).
Krishnan, A. V., Swami, S. & Feldman, D. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J.Steroid Biochem.Mol.Biol. 121, 343–348 (2010).
Swami, S., Krishnan, A. V. & Feldman, D. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clinical cancer research: an official journal of the American Association for. Cancer Research 6, 3371–3379 (2000).
Stoica, A. et al. Regulation of estrogen receptor-alpha gene expression by 1,25-dihydroxyvitamin D in MCF-7 cells. J Cell Biochem 75, 640–651 (1999).
Soule, H. D. et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Research 50, 6075–6086 (1990).
Krause, S., Maffini, M. V., Soto, A. M. & Sonnenschein, C. A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Eng. Part C Methods 14, 261–271 (2008).
Dhimolea, E., Soto, A. M. & Sonnenschein, C. Breast epithelial tissue morphology is affected in 3D cultures by species-specific collagen-based extracellular matrix. J. Biomed. Mat. Res. A 100, 2905–2912 (2012).
Sweeney, M. F., Sonnenschein, C. & Soto, A. M. Characterization of MCF-12A cell phenotype, response to estrogens, and growth in 3D. Cancer Cell Int. 18, 43 (2018).
Barnes, C. et al. From single cells to tissues: interactions between the matrix and human breast cells in real time. PLoS ONE 9, e93325 (2014).
Liu, Z. et al. 3D organizational mapping of collagen fibers elucidates matrix remodeling in a hormone-sensitive 3D breast tissue model. Biomaterials 179, 96–108, https://doi.org/10.1016/j.biomaterials.2018.06.036 (2018).
Gjorevski, N. & Nelson, C. M. Integrated morphodynamic signalling of the mammary gland. Nature reviews. Molecular cell biology 12, 581–593, https://doi.org/10.1038/nrm3168 (2011).
Vandenberg, L. N. et al. Hormones and endocrine disrupting chemicals: low dose effects and non-monotonic dose responses. Endocrine Reviews 33, 378–455 (2012).
Sheng, L. et al. Conditional inactivation of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) in the mouse mammary epithelium alters mammary gland development. San Antonio Breast Cancer Symposium (2016).
Freake, H. C., Marcocci, C., Iwasaki, J. & MacIntyre, I. 1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth. Biochem Biophys Res Commun 101, 1131–1138 (1981).
Eisman, J. A., Sher, E., Suva, L. J., Frampton, R. J. & McLean, F. L. 1 alpha, 25-Dihydroxyvitamin D3 specifically induces its own metabolism in a human cancer cell line. Endocrinology 114, 1225–1231, https://doi.org/10.1210/endo-114-4-1225 (1984).
Fendrick, J. L., Raafat, A. M. & Haslam, S. Z. Mammary gland growth and development from the postnatal period to postmenopause: Ovarian steroid receptor ontogeny and regulation in the mouse. Journal of Mammary Gland Biology and Neoplasia 3, 7–22 (1998).
Montévil, M., Speroni, L., Sonnenschein, C. & Soto, A. M. Modeling mammary organogenesis from biological first principles: Cells and their physical constraints. Progress in Biophysics and Molecular Biology 122, 58–69 (2016).
Schedin, P. & Keely, P. J. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb. Perspect. Biol. 3, a003228 (2011).
Guo, C. L. et al. Long-range mechanical force enables self-assembly of epithelial tubular patterns. Proceedings of the National Academy of Science of the United States of America 109, 5576–5582 (2012).
Dhimolea, E., Maffini, M. V., Soto, A. M. & Sonnenschein, C. The role of collagen reorganization on mammary epithelial morphogenesis in a 3D culture model. Biomaterials 31, 3622–3630 (2010).
Novaro, V., Roskelley, C. D. & Bissell, M. J. Collagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells. Journal of Cell Science 116, 2975–2986 (2003).
Linnemann, J. R. et al. Quantification of regenerative potential in primary human mammary epithelial cells. Development 142, 3239–3251 (2015).
Sokol, E. S. et al. Growth of human breast tissues from patient cells in 3D hydrogel scaffolds. Breast Cancer Res. 18, 19 (2016).
Speroni, L. et al. New insights into fetal mammary gland morphogenesis: differential effects of natural and environmental estrogens. Scientific Reports 7, 40806 (2017).
Dhimolea, E. et al. Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development. PLoS ONE 9, e99800 (2014).
Soto, A. M. et al. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environmental Health Perspectives 103, 113–122 (1995).
Skehan, P. et al. New colorimetric cytotixicity assay for anticancer-drug screening. Journal of the National Cancer Institute 82, 1107–1112 (1990).
Junqueira, L. C., Bignolas, G. & Brentani, R. R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochemistry Journal 11, 447–455 (1979).
We would like to thank Cheryl Schaeberle for her help with statistical analyses and a critical reading of this manuscript. This work was supported by the National Institute of Environmental Health Sciences grant ES08314, and the NIH Research Infrastructure grant S10 OD021624. The content does not necessarily represent the official views of the funding agencies.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hasan, N., Sonnenschein, C. & Soto, A.M. Vitamin D3 constrains estrogen’s effects and influences mammary epithelial organization in 3D cultures. Sci Rep 9, 7423 (2019). https://doi.org/10.1038/s41598-019-43308-1